Enlightify Inc. Seeks to Cure Price Deficiency to Maintain NYSE Listing

miércoles, 10 de septiembre de 2025, 5:02 pm ET1 min de lectura
ENFY--

Enlightify Inc. has notified the New York Stock Exchange of its intention to cure the price deficiency that resulted from its 30-trading-day average closing price per share being below $1.00. The company has six months to regain compliance and avoid delisting. Its common stock continues to be listed and traded on the NYSE, subject to other continued listing requirements.

Enlightify Inc. Seeks to Cure Price Deficiency to Maintain NYSE Listing

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios